NO20076317L - Sammensetning av en tienopyridinblodplateaggregeringsinhibitor - Google Patents

Sammensetning av en tienopyridinblodplateaggregeringsinhibitor

Info

Publication number
NO20076317L
NO20076317L NO20076317A NO20076317A NO20076317L NO 20076317 L NO20076317 L NO 20076317L NO 20076317 A NO20076317 A NO 20076317A NO 20076317 A NO20076317 A NO 20076317A NO 20076317 L NO20076317 L NO 20076317L
Authority
NO
Norway
Prior art keywords
composition
platelet aggregation
aggregation inhibitor
thienopyridine
thienopyridine platelet
Prior art date
Application number
NO20076317A
Other languages
English (en)
Inventor
David Brian Dziennik
Tamara Beth Edelman
Peter Lloyd Oren
Robert Louis Ternik
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=37198935&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO20076317(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of NO20076317L publication Critical patent/NO20076317L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/4365—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system having sulfur as a ring hetero atom, e.g. ticlopidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Epidemiology (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Vascular Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Pulmonology (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)

Abstract

Formulering av en forbindelse av formel (I) for behandling og fremgangsmåter for anvendelse er fremlagt
NO20076317A 2005-06-10 2007-12-07 Sammensetning av en tienopyridinblodplateaggregeringsinhibitor NO20076317L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US68918305P 2005-06-10 2005-06-10
PCT/US2006/021860 WO2006135605A2 (en) 2005-06-10 2006-06-06 Formulation of a thienopyridine platelet aggregation inhibitor

Publications (1)

Publication Number Publication Date
NO20076317L true NO20076317L (no) 2008-02-29

Family

ID=37198935

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20076317A NO20076317L (no) 2005-06-10 2007-12-07 Sammensetning av en tienopyridinblodplateaggregeringsinhibitor

Country Status (35)

Country Link
US (1) US20080176893A1 (no)
EP (1) EP1896019B1 (no)
JP (1) JP2008543755A (no)
KR (2) KR20080008413A (no)
CN (1) CN101193633B (no)
AR (1) AR054283A1 (no)
AT (1) ATE441413T1 (no)
AU (1) AU2006258102B2 (no)
BR (1) BRPI0611350B8 (no)
CA (1) CA2611668C (no)
CY (1) CY1109502T1 (no)
DE (1) DE602006008942D1 (no)
DK (1) DK1896019T3 (no)
DO (1) DOP2006000126A (no)
EA (1) EA011693B1 (no)
EC (1) ECSP077984A (no)
ES (1) ES2330373T3 (no)
HK (1) HK1116422A1 (no)
HR (1) HRP20090516T1 (no)
IL (1) IL187830A0 (no)
MA (1) MA29688B1 (no)
MX (1) MX2007015431A (no)
MY (1) MY151038A (no)
NO (1) NO20076317L (no)
NZ (1) NZ564003A (no)
PE (1) PE20070320A1 (no)
PL (1) PL1896019T3 (no)
PT (1) PT1896019E (no)
RS (1) RS51194B (no)
SI (1) SI1896019T1 (no)
TN (1) TNSN07466A1 (no)
TW (1) TWI318571B (no)
UA (1) UA91051C2 (no)
WO (1) WO2006135605A2 (no)
ZA (1) ZA200710697B (no)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2101767A2 (en) * 2006-12-07 2009-09-23 Eli Lilly & Company An article comprising prasugrel
EP2100607A4 (en) * 2006-12-07 2010-01-06 Daiichi Sankyo Co Ltd PHARMACEUTICAL COMPOSITION HAVING ENHANCED STORAGE STABILITY
US20090291138A1 (en) * 2006-12-07 2009-11-26 Daiichi Sankyo Company, Limited Film-coated preparation having improved stability
KR101442862B1 (ko) * 2006-12-07 2014-09-22 다이이찌 산쿄 가부시키가이샤 만니톨 또는 유당을 함유하는 고형 제제
EP2100610A4 (en) * 2006-12-07 2009-12-02 Daiichi Sankyo Co Ltd PHARMACEUTICAL COMPOSITION WITH LOW SUBSTITUTED HYDROXYPROPYL CELLULOSE
TWI405591B (zh) * 2006-12-07 2013-08-21 Daiichi Sankyo Co Ltd 固形製劑之製造方法
MY151726A (en) * 2007-03-02 2014-06-30 Daiichi Sankyo Co Ltd Process for production of prasugrel hydrochloride having high purity
HUE053158T2 (hu) 2007-04-27 2021-06-28 Cydex Pharmaceuticals Inc Clopidogrelt és szulfoalkiléter ciklodextrint tartalmazó készítmények és alkalmazási eljárások
GB2450117A (en) * 2007-06-13 2008-12-17 Reckitt Benckiser Healthcare A water- and oxygen-occlusive blister tablet pack
US20110003847A1 (en) * 2008-02-06 2011-01-06 Helm Ag Prasugrel Salts with Improved Properties
EP2107061A1 (en) * 2008-04-02 2009-10-07 Krka Tovarna Zdravil, D.D., Novo Mesto Process for the preparation of optically enriched clopidogrel
ATE482961T1 (de) * 2008-04-25 2010-10-15 Sandoz Ag Hydrogensulfat von 2-acetoxy-5-(a- cyclopropylcarbonyl-2-fluorbenzyl)-4,5,6,7- tetrahydrothienoä3,2-cüpyridin und dessen zubereitung
EP2398468B1 (en) 2009-02-17 2016-11-30 KRKA, D.D., Novo Mesto Pharmaceutical compositions comprising prasugrel base or its pharmaceutically acceptable acid addition salts and processes for their preparation
PL3100728T3 (pl) * 2009-05-13 2020-05-18 Cydex Pharmaceuticals, Inc. Kompozycje farmaceutyczne zawierające prasugrel i pochodne cyklodekstryny oraz sposoby ich wytwarzania i zastosowania
DE102009036646A1 (de) 2009-08-07 2011-02-10 Ratiopharm Gmbh Prasugrel in nicht-kristalliner Form und pharmazeutische Zusammensetzung davon
WO2011052499A1 (ja) * 2009-10-28 2011-05-05 第一三共株式会社 貯蔵安定性が改善された医薬組成物
JP2013032289A (ja) * 2009-10-28 2013-02-14 Daiichi Sankyo Co Ltd ワックス安定製剤
WO2011092720A2 (en) * 2010-02-01 2011-08-04 Msn Laboratories Limited Pharmaceutical composition of prasugrel and its pharmaceutically acceptable salts
TR201005900A1 (tr) 2010-07-19 2012-02-21 Sanovel İlaç San. Ve Ti̇c. A.Ş. Geliştirilmiş stabiliteye sahip prasugrel granülleri.
TR201006802A1 (tr) * 2010-08-17 2012-03-21 Sanovel İlaç San. Ve Ti̇c. A.Ş. Prasugrelin oral yolla dağılan formülasyonları.
TR201007926A1 (tr) 2010-07-19 2012-02-21 Sanovel İlaç San.Ve Ti̇c.A.Ş. Prasugrel tablet formülasyonları.
EP2409685A3 (en) 2010-07-19 2012-02-01 Sanovel Ilac Sanayi ve Ticaret A.S. Orally-disintegrating formulations of prasugrel
CZ2011872A3 (cs) 2011-12-22 2013-07-03 Zentiva, K.S. Farmaceutická formulace prasugrelu hydrobromidu
US8603537B2 (en) 2012-04-02 2013-12-10 Egis Pharmaceuticals Plc Prasugrel containing quickly released stable oral pharmaceutical compositions
EP2722037A1 (en) 2012-10-19 2014-04-23 Sanovel Ilac Sanayi ve Ticaret A.S. Prasugrel formulations
EP2722036A1 (en) 2012-10-19 2014-04-23 Sanovel Ilac Sanayi ve Ticaret A.S. Solid oral formulations of prasugrel
CN102993210A (zh) * 2012-12-19 2013-03-27 苏春华 一种吡啶并噻吩的新化合物
EP2979693A1 (en) 2014-08-01 2016-02-03 Zaklady Farmaceutyczne Polpharma SA Pharmaceutical composition comprising prasugrel or pharmaceutically acceptable salt thereof and process for its preparation
WO2016122421A1 (en) 2015-01-29 2016-08-04 Pharmactive Ilaç Sanayi Ve Ticaret A.Ş. Stable pharmaceutical compositions containing prasugrel base
EP3158993A1 (en) 2015-10-22 2017-04-26 Zaklady Farmaceutyczne Polpharma SA Process for preparing a tablet comprising prasugrel or pharmaceutically acceptable salt thereof
CN107304216A (zh) * 2016-04-20 2017-10-31 陕西合成药业股份有限公司 噻吩吡啶类衍生物及其制备方法和用途
HU231079B1 (hu) 2016-06-23 2020-06-29 Richter Gedeon Nyrt. Eljárás nagytisztaságú Prasugrel előállítására bromopentil szennyezés eltávolításával
GR1009230B (el) 2016-10-12 2018-02-22 Φαρματεν Αβεε Φαρμακευτικο σκευασμα που περιλαμβανει βεσυλικη πρασουγρελη

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI101150B (fi) * 1991-09-09 1998-04-30 Sankyo Co Menetelmä lääkeaineina käyttökelpoisten tetrahydrotienopyridiinin johd annaisten valmistamiseksi
JP4001199B2 (ja) * 2000-07-06 2007-10-31 第一三共株式会社 ヒドロピリジン誘導体酸付加塩
CN1214031C (zh) * 2000-07-06 2005-08-10 三共株式会社 氢化吡啶衍生物酸加成盐
EP1243524A3 (en) * 2001-03-16 2004-04-07 Pfizer Products Inc. Pharmaceutical kit for oxygen-sensitive drugs
JP4394873B2 (ja) * 2001-12-19 2010-01-06 武田薬品工業株式会社 酸素に不安定な化合物を含有する固形組成物およびその安定化方法
SI21302A (sl) * 2002-10-11 2004-04-30 LEK farmacevtska dru�ba d.d. Stabiliziran farmacevtski izdelek z amorfno aktivno učinkovino
US20050020554A1 (en) * 2003-06-06 2005-01-27 Ahmed Salah U. Stability of hormone formulations
CA2535225A1 (en) * 2003-08-05 2005-02-10 Zentiva, A.S. Methods for the stabilization of atorvastatin

Also Published As

Publication number Publication date
UA91051C2 (ru) 2010-06-25
EP1896019A2 (en) 2008-03-12
AU2006258102A1 (en) 2006-12-21
ES2330373T3 (es) 2009-12-09
SI1896019T1 (sl) 2010-01-29
CA2611668C (en) 2013-10-15
ECSP077984A (es) 2008-01-23
KR20100076050A (ko) 2010-07-05
MA29688B1 (fr) 2008-08-01
DOP2006000126A (es) 2006-12-15
BRPI0611350B1 (pt) 2020-09-15
WO2006135605A3 (en) 2007-04-12
KR20080008413A (ko) 2008-01-23
EA200702670A1 (ru) 2008-04-28
CN101193633A (zh) 2008-06-04
MY151038A (en) 2014-03-31
EP1896019B1 (en) 2009-09-02
HRP20090516T1 (en) 2009-10-31
DK1896019T3 (da) 2009-10-26
RS51194B (sr) 2010-10-31
DE602006008942D1 (en) 2009-10-15
PT1896019E (pt) 2009-11-19
TNSN07466A1 (en) 2009-03-17
MX2007015431A (es) 2008-02-21
BRPI0611350B8 (pt) 2021-05-25
PL1896019T3 (pl) 2010-01-29
PE20070320A1 (es) 2007-05-12
JP2008543755A (ja) 2008-12-04
WO2006135605A2 (en) 2006-12-21
BRPI0611350A2 (pt) 2010-12-07
NZ564003A (en) 2011-07-29
TW200718420A (en) 2007-05-16
HK1116422A1 (en) 2008-12-24
AU2006258102B2 (en) 2011-09-15
ZA200710697B (en) 2009-08-26
TWI318571B (en) 2009-12-21
CA2611668A1 (en) 2006-12-21
ATE441413T1 (de) 2009-09-15
CY1109502T1 (el) 2014-08-13
IL187830A0 (en) 2008-04-13
US20080176893A1 (en) 2008-07-24
AR054283A1 (es) 2007-06-13
CN101193633B (zh) 2011-12-14
EA011693B1 (ru) 2009-04-28

Similar Documents

Publication Publication Date Title
NO20076317L (no) Sammensetning av en tienopyridinblodplateaggregeringsinhibitor
NZ585460A (en) Inhibitors of human phosphatidyl-inositol 3-kinase delta
CY1108445T1 (el) Νεα μεθοδος συνθεσης και νεα κρυσταλλικη μορφη της αγομελατινης καθως και φαρμακευτικες συνθεσεις που την περιεχουν
NO20073791L (no) Pyrazolylaminopyridinderivater anvendbare som kinaseinhibitorer
CY1107168T1 (el) Παραγωγα φαινυλοαλκανοϊκου οξεος και φαινυλοξυαλκανοϊκου οξεος ως ενεργοποιηται hppar
NO20043587L (no) Nye heterocykliske forbindelser som er aktive som inhibitorer av beta-laktamaser
CY1113011T1 (el) Νεα κρυσταλλικη μορφη v της αγομελατινης, μεθοδος παρασκευης αυτης και φαρμακευτικες συνθεσεις που περιεχουν αυτην
NO20085317L (no) Imidazoazepinonforbindelser
PE20110062A1 (es) N-(3-(3,5-dimetoxifenetil)-1h-pirazol-5-il)-4-(3,4-dimetilpiperazin-1-il)benzamida y sales del mismo
EA201291356A1 (ru) Пиперидиноновые производные как ингибиторы mdm2 для лечения рака
EA201071019A1 (ru) Кристаллические формы производных фениламинопиримидина
EA201001455A1 (ru) Пиридины и пиразины в качестве ингибиторов pi3k (фосфатидилинозиткиназы-3)
PE20091065A1 (es) Derivados bis-(sulfonilamino) en terapia 066
CY1108738T1 (el) Θεραπευτικοι παραγοντες χρησιμοι για την αγωγη του πονου
JO3121B1 (ar) مشتقات 1 - ((5-هيتيرورلثيازول-2-يل) أمينوكاربونيل) بيروليدين-2-كربوكساميد كمثبات الفوسفاتديلينوسيتول 3-كيناس (pi3k) مفيدة في علاج الأمراض التصاعدية
EA201000113A1 (ru) Пиразольные соединения
NO20085217L (no) Effektive pyrimidinderivater i behandlingen av kreft
RS52601B (en) BENZOTIAZEPINE DERIVATIVES AS A RYANODIN (RYR2) RECEPTOR INHIBITOR AND THEIR USE IN THE TREATMENT OF HEART DISEASES
NO20090994L (no) 2-aminobenzoxazol karboxamider som 5HT3 modulatorer
MX2009005357A (es) Derivados de hidantoina usados como inhibidores de metaloproteinasas de matriz.
ATE423122T1 (de) Kondensierte heterocyclen als inhibitoren von glutamatracemase (muri)
EA200801996A1 (ru) 2-замещенные производные 4-бензилфталазинонов в качестве гистаминовых h1- и h3-антагонистов
PE20081354A1 (es) Compuestos de azaindolilo como inhibidores de mek
CY1110036T1 (el) Μεθοδος συνθεσης του ρανελικου στροντιου και των ενυδρων αλατων του
EA200801145A1 (ru) Спироциклические производные хиназолина в качестве ингибиторов pde7

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application